Uniphos Enterprises Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Uniphos Enterprises heeft een totaal eigen vermogen van ₹25.8B en een totale schuld van ₹400.0M, wat de schuld-eigenvermogensverhouding op 1.6% brengt. De totale activa en totale passiva bedragen respectievelijk ₹26.9B en ₹1.2B.

Belangrijke informatie

1.6%

Verhouding schuld/eigen vermogen

₹400.00m

Schuld

Rente dekkingsratio	n/a
Contant	₹537.51m
Aandelen	₹25.78b
Totaal verplichtingen	₹1.17b
Totaal activa	₹26.94b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Lacklustre Performance Is Driving Uniphos Enterprises Limited's (NSE:UNIENTER) Low P/E

Oct 08

There's Been No Shortage Of Growth Recently For Uniphos Enterprises' (NSE:UNIENTER) Returns On Capital

Jun 01

Should You Rely On Uniphos Enterprises's (NSE:UNIENTER) Earnings Growth?

Nov 04

Will The ROCE Trend At Uniphos Enterprises (NSE:UNIENTER) Continue?

Jun 29

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹645.5M ) UNIENTER } overtreffen de korte termijn passiva ( ₹144.6M ).

Langlopende schulden: De kortetermijnactiva van UNIENTER ( ₹645.5M ) dekken de langetermijnschulden ( ₹1.0B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: UNIENTER heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van UNIENTER is de afgelopen 5 jaar gestegen van 0% naar 1.6%.

Schuldendekking: De operationele kasstroom van UNIENTER is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van UNIENTER op haar schulden goed worden gedekt door EBIT.

Uniphos Enterprises Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Lacklustre Performance Is Driving Uniphos Enterprises Limited's (NSE:UNIENTER) Low P/E

Uniphos Enterprises Limited Announces Board Appointments

Investor sentiment improves as stock rises 15%

Upcoming dividend of ₹5.70 per share

Uniphos Enterprises Limited, Annual General Meeting, Sep 20, 2024

Uniphos Enterprises Limited to Report Q1, 2025 Results on Aug 13, 2024

Uniphos Enterprises Limited Recommends Dividend for the Financial Year Ended March 31, 2024

Uniphos Enterprises Limited to Report Q4, 2024 Results on May 28, 2024

Uniphos Enterprises Limited to Report Q3, 2024 Results on Feb 13, 2024

Uniphos Enterprises Limited Approves Dividend for the Year Ended March 31, 2023

Full year 2023 earnings released: EPS: ₹5.64 (vs ₹7.85 in FY 2022)

Upcoming dividend of ₹6.50 per share at 3.7% yield

Uniphos Enterprises Limited, Annual General Meeting, Aug 25, 2023

New major risk - Dividend sustainability

Uniphos Enterprises Limited Recommends Dividend for the Financial Year Ended 31 March, 2023

Uniphos Enterprises Limited to Report Q4, 2023 Results on May 26, 2023

Investor sentiment improves as stock rises 18%

Uniphos Enterprises Limited to Report Q3, 2023 Results on Feb 14, 2023

Insufficient new directors

Insufficient new directors

Uniphos Enterprises Limited to Report Q2, 2023 Results on Nov 14, 2022

Uniphos Enterprises Limited Approves Dividend for the Financial Year Ended 31 March, 2022

Uniphos Enterprises Limited to Report Q1, 2023 Results on Aug 12, 2022

Upcoming dividend of ₹5.65 per share

Uniphos Enterprises Limited, Annual General Meeting, Aug 19, 2022

Uniphos Enterprises Limited Recommends Dividend

Full year 2022 earnings released: EPS: ₹7.85 (vs ₹3.52 in FY 2021)

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₹3.40 per share

Full year 2021 earnings released: EPS ₹3.52 (vs ₹2.89 in FY 2020)

There's Been No Shortage Of Growth Recently For Uniphos Enterprises' (NSE:UNIENTER) Returns On Capital

Investor sentiment improved over the past week

Uniphos Enterprises Limited Recommends Dividend for the Year Ended March 31, 2021

Investor sentiment improved over the past week

Independent & Non-Executive Director recently sold ₹1.3m worth of stock

New 90-day high: ₹84.55

New 90-day high: ₹82.70

Investor sentiment improved over the past week

New 90-day high: ₹71.80

New 90-day high: ₹67.45

Independent & Non-Executive Director recently sold ₹51m worth of stock

New 90-day low: ₹59.45

Uniphos Enterprises Limited Directors Rejects Resignation of K. M. Thacker as Company Secretary and Compliance Officer

Should You Rely On Uniphos Enterprises's (NSE:UNIENTER) Earnings Growth?

Uniphos Enterprises Limited Announces Resignation of K. M. Thacker as Company Secretary and Compliance Officer

New 90-day high: ₹69.30

Uniphos Enterprises Limited to Report Q3, 2021 Results on Feb 14, 2021

New 90-day high - ₹67.35

First quarter earnings released

Will The ROCE Trend At Uniphos Enterprises (NSE:UNIENTER) Continue?

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven